Clover Health Investments, Corp.

NASDAQ:CLOV

3.66 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 336.963330.986356.26346.922510.251306.028320.138321.992898.791856.817846.7874.379432.036427.163412.472200.325-506.655169.069172.081165.5050118.384117.905117.905
Cost of Revenue 243.044249.774248.347265.162447.985235.785244.262274.789893.645839.799858.786861.722441.803436.325458.503214.420144.846119.366146.3280000
Gross Profit 93.91981.212107.91381.7662.26670.24375.87647.2035.14617.018-12.08612.657-9.767-9.162-46.031-14.095024.22352.71519.1770118.384117.905117.905
Gross Profit Ratio 0.2790.2450.3030.2360.1220.230.2370.1470.0060.02-0.0140.014-0.023-0.021-0.112-0.0700.1430.3060.1161111
Reseach & Development Expenses 000000000000000000000000
General & Administrative Expenses 115.02390.19699.923103.792109.929101.597104.147126.625124.349117.974117.531126.788114.207119.21107.813104.642046.47540.69549.967019.6922.95322.953
Selling & Marketing Expenses 00000000000000000000017.17126.34926.349
SG&A 115.02390.19699.923103.792109.929101.597104.147126.625124.349117.974117.531126.788114.207119.21107.813104.642046.47540.69549.967036.86149.30249.302
Other Expenses 0.344-0.1990.8030.67117.9972.2620.6110.276-12.04-26.86-26.89-26.6562.81520.88128.0180.351-524.871-0.634-11.15-4.160.018000
Operating Expenses 115.36789.997100.726104.463127.926103.859104.758126.901112.30991.11490.641100.138177.022140.091135.831104.993-524.87145.84129.54545.8070.018162.568230.527230.527
Operating Income -21.448-8.7857.187-22.703-65.66-33.616-28.882-79.698-107.163-74.096-102.727-87.481-186.789-149.253-181.862-119.08818.216-21.61823.17-26.63-0.018-30.853-44.286-44.286
Operating Income Ratio -0.064-0.0270.02-0.066-0.13-0.086-0.056-0.138-0.119-0.086-0.121-0.1-0.432-0.349-0.441-0.594-0.407-0.1280.135-0.161-0-0.261-0.376-0.376
Total Other Income Expenses Net -0.0330-0.017-0.467-4.8120-0.007023.117-1.393-1.63511.991-0.412114.726-135.74970.671-14.9634.376-17.767-1.5320-20.811-72.415-72.415
Income Before Tax -21.481-8.7857.17-23.17-70.472-33.616-28.889-79.698-84.046-75.489-104.362-75.49-187.201-34.527-317.611-48.4173.25612.7585.403-28.162-0.018-51.664-116.701-116.701
Income Before Tax Ratio -0.066-0.0280.02-0.067-0.139-0.086-0.056-0.138-0.094-0.088-0.123-0.086-0.433-0.081-0.77-0.242-0.4910.0750.031-0.17-0-0.436-0.99-0.99
Income Tax Expense 000000000000000000000-20.811-72.415-72.415
Net Income -22.092-9.1557.408-19.17-70.472-41.469-28.814-72.606-84.046-75.489-104.362-75.49-187.201-34.527-317.611-48.4173.25612.7585.403-28.162-0.018-51.664-116.701-116.701
Net Income Ratio -0.066-0.0280.021-0.055-0.139-0.086-0.056-0.138-0.069-0.089-0.123-0.072-0.433-0.081-0.77-0.242-0.4910.0750.031-0.17-0-0.436-0.99-0.99
EPS -0.045-0.020.01-0.04-0.15-0.09-0.06-0.16-0.18-0.16-0.22-0.16-0.4-0.082-0.78-0.13-0.20.0320.005-0.070-1.21-2.76-2.76
EPS Diluted -0.045-0.020.01-0.04-0.15-0.09-0.06-0.16-0.18-0.16-0.22-0.16-0.4-0.082-0.78-0.13-0.20.0320.005-0.070-1.21-2.76-2.76
EBITDA -21.137-8.4467.5-22.032-69.798-33.059-27.883-77.612-84.748-74.46-103.368-74.261-185.941-33.981-316.256-33.422-37.35626.57218.848-14.513-0.018-20.811-72.415-72.415
EBITDA Ratio -0.063-0.0260.022-0.061-0.093-0.082-0.045-0.137-0.119-0.086-0.121-0.099-0.43-0.349-0.441-0.594-0.406-0.1270.136-0.16-0-0.176-0.614-0.614